Clinical trial
Metformin in Patients With Unruptured Vertebrobasilar Dissecting Aneurysms: a Prospective, Randomized Study (METTLE)
NCT06405971 is registered in ClinicalTrials.gov with Ming Lv as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin in Patients With Unruptured Vertebrobasilar Dissecting Aneurysms: a Prospective, Randomized Study (METTLE)
- Lead sponsor
- Ming Lv
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2024
- Completion date
- June 1, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dissecting aneurysm of cerebral artery